InBrain raises US$50 million for brain-computer interface
Cette publication existe aussi en Français
InBrain Neuroelectronics (Barcelona, Spain), a brain-computer interface (BCI) company developing graphene-based neural technologies, has closed of a US$50 million Series B financing round.
This brings the total amount raised by the company since its formation in 2020 to US$68 million.
The funding round was led by IMEC.xpand with participation from the EIC Fund, the venture capital arm of the European Innovation Council. The money will be used to support clinical trials for BCI therapeutics and to support expansion and development.
As part of the funding round nanoelectronics research institute IMEC has agreed to support InBrain in scaling the production of graphene interfaces to a commercial level.
InBrain has also secured additional funding and support from Merck KGaA to advance the clinical development of the technology in Merck’s therapeutic areas of interest. This partnership will boost the use of InBrain’s platform for human use, across both central and peripheral nervous system applications.
The InBrain implant is about 10-microns thick and the AI-driven system combines neural decoding and signal modulation to deliver real-time adaptive treatments for conditions such as Parkinson’s disease, epilepsy, and stroke rehabilitation. The system has been granted a “breakthrough device” designation from the US Food and Drug Administration (FDA) for its application to Parkinson’s Disease.
“We are excited to have the support of a top-tier syndicate as we work to bring this technology to patients in need of more precise, personalized treatments,” said Carolina Aguilar, CEO and co-founder of InBrain, in a statement.
The first human application of InBrain’s BCI was administered in a trial at Salford Royal Hospital in Manchester, England, in September 2024.
Related links and articles:
www.inbrain-neuroelectronics.com
News articles:
First human receives brain-computer interface from Neuralink
CEO interview: with Katrin Kobe of Bosch Quantum Sensing
Next-gen brain implant uses a graphene chip